By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Vitiligo Trial to Initiate in Mid-2026 Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of EB06, its ...

Around one in every 100 people worldwide has vitiligo – a chronic, autoimmune skin condition that causes the skin to appear ...

The FDA approved ruxolitinib cream 1.5% (Opzelura) for non-segmental vitiligo in adults and children 12 years and older, making it the only FDA-approved treatment for repigmentation in vitiligo and ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease ...

US-based pharmaceutical company VYNE Therapeutics has completed enrolment in the randomised Phase IIb clinical trial of VYN201 gel, known as repibresib, for treating non-segmental vitiligo. The double ...

Please provide your email address to receive an email when new articles are posted on . Patients applying topical ruxolitinib twice-daily saw better outcomes than those applying once-daily (15% vs. 10 ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Winnie Harlow has been in the news this week, owning the red carpet at Haute Couture week in Paris. The 22-year-old Canadian model has vitiligo, which has given her distinctive white patches on her ...

(RTTNews) - AbbVie (ABBV) announced Thursday that its Phase 2b study evaluating upadacitinib (RINVOQ) in adults with non-segmental vitiligo or NSV met the primary endpoint. Based on the data, the ...

(RTTNews) - AbbVie (ABBV) on Tuesday said it has submitted applications to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of Rinvoq for the treatment ...

Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more ...